Sanofi-Aventis Sues Over Eloxatin Ingredient
Sanofi-Aventis has filed suit against W.C. Heraeus GmbH, claiming the German precious metals company is aiding infringement of a patent for Sanofi's colon cancer drug Eloxatin by providing an important active...To view the full article, register now.
Already a subscriber? Click here to view full article